Home Products Foretinib
Foretinib
Synonyms: GSK1363089,GSK089,XL880,EXEL-2880
CAS NO: 849217-64-7
Molecular Formula: C34H34F2N4O6
Molecular Weight: 632.65
Purity: 98% min
Solubility: In DMSO
Storage: −20°C
Availability and Price
25MG/$300 In Stock If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.
50MG/$500 In Stock
100MG/$800 In Stock Order       Order Infomation
200MG/$1500 In-stock
Shipping and handling fee USD40
Free delivery is qualified when the total value of your order exceeds 500USD
Remarks: Foretinib(GSK1363089, XL880) is a novel MET and VEGFR2/KDR kinases inhibitor with an IC50 of 0.4 and 0.8 nM for MET and KDR, respectively. Foretinib(GSK1363089, XL880) inhibits HGF receptor family tyrosine kinases with an IC50 of 3 nM for Ron. Foretinib(GSK1363089, XL880) also inhibits KDR, Flt-1, and Flt-4 with IC50 of 0.9, 6.8 and 2.8 nM, respectively. In addition, EXEL-2880 inhibits members of the platelet-derived growth factor receptor family and the angiopoietin-1 receptor Tie-2. Foretinib(GSK1363089, XL880) exhibits modest activity against fibroblast growth factor receptor 1 and epidermal growth factor receptor and is inactive against 50 serine/threonine kinases, including cyclin-dependent kinases and protein kinase C isoforms. To delineate the cellular effect of Foretinib(GSK1363089, XL880), VEGF- induced extracellular signal-regulated kinase phosphorylation was used to assess the effect of the compound on phosphorylation of KDR in human umbilical vein endothelial cells that resulted in an IC50 of 16 nM. Foretinib(GSK1363089, XL880) is the 1st orally available small molecule inhibitor of Met to enter the clinic and appears to be generally well tolerated. Anti-tumor activity has been observed and Foretinib may represent an active treatment option for patients with papillary renal-cell carcinoma.

Quality Control

Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Related Products
c-Met Inhibitors
 

None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer.

Our products are for research use only, not for human use.
 
Homepage | About Us | Products | News&Events | Custom Synthesis | Order Infomation | Contact Us
Friendly link: molbase   Copyright © Taizhou Crene Biotechnology Co.,Ltd. 技术支持:趋势科技